Results 91 to 100 of about 243,764 (341)

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects

BioMed Research International, 2014
Antipsychotic-induced extrapyramidal adverse effects are well recognized in the context of first-generation antipsychotic drugs. However, the introduction of second-generation antipsychotics, with atypical mechanism of action, especially lower dopamine ...
N. Divac, M. Prostran, I. Jakovcevski, Natasa Cerovac   +3 more
semanticscholar   +1 more source

Pharmacogenomics of Major Depressive Disorder in Indigenous Amazonian Populations

Clinical Pharmacology &Therapeutics, EarlyView.
Major depressive disorder is a highly prevalent psychological disorder worldwide and its main treatment is the use of Selective Serotonin Reuptake Inhibitors. However, few studies have demonstrated the relationship between the presence of genetic variants in pharmacogenes and the efficacy of these drugs, especially in populations with a unique genetic ...
Kaio Evandro Cardoso Aguiar, Natasha Monte da Silva, Juliana Carla Gomes Rodrigues, André Maurício Ribeiro‐dos‐Santos, Sandro José de Souza, Ândrea Ribeiro‐dos‐Santos, João Farias Guerreiro, Sidney Emanuel Batista dos Santos, Marianne Rodrigues Fernandes, Ney Pereira Carneiro dos Santos   +9 more
wiley   +1 more source

Role of community pharmacists in the use of antipsychotics for behavioural and psychological symptoms of dementia (BPSD): A qualitative study [PDF]

, 2016
Objective This study aimed to use qualitative methodology to understand the current role of community pharmacists in limiting the use of antipsychotics prescribed inappropriately for behavioural and psychological symptoms of dementia.
Aston, Lydia, Child, Anne, Hilton, Andrea, Iqbal, Naveed, Maidment, Ian D., Shaw, Rachel   +5 more
core   +2 more sources

Association of typical and atypical antipsychotics with mortality in older adults with schizophrenia: a 5-year multicenter prospective study

Brazilian Journal of Psychiatry
Objective: Due to the uncertainty whether atypical and typical antipsychotics have a stronger association with mortality among older people with schizophrenia, we examined the rates and causes of mortality in older adults with schizophrenia who take ...
Raphaëlle Haddad, Marina Sánchez-Rico, Katayoun Rezaei, Sandra Abou Kassm, Carlos Blanco, Mark Olfson, Frédéric Limosin, Nicolas Hoertel   +7 more
doaj   +1 more source

Attitudes of European physicians towards the use of long-acting injectable antipsychotics

BMC Psychiatry, 2020
Background Prescription rates for long-acting injectable (LAI) antipsychotic formulations remain relatively low in Europe despite improved adherence over alternative oral antipsychotic treatments.
Maxine X. Patel, Nawal Bent-Ennakhil, Christophe Sapin, Sylvie di Nicola, Jean-Yves Loze, Anna-Greta Nylander, Stephan Heres   +6 more
doaj   +1 more source

Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies

Clinical Pharmacology &Therapeutics, EarlyView.
Maternal health remains a critical global concern, particularly in underserved populations and in low‐ and middle‐income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data ...
Rachel K. Scott, Sharon Nachman, Ethel D. Weld, Rachel Daley, Shakir Atoyebi, Robert Bies, Catriona Waitt, Adeniyi Olagunju   +7 more
wiley   +1 more source

The Relationship Between Precuneus Thickness and Psychopathology in Adolescent Females With Anorexia Nervosa

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Anorexia nervosa (AN) is a severe psychiatric disorder with structural brain alterations; however, the roles of cortical surface area (CSA) and cortical thickness (CTh) during adolescence remain unclear. Building on frequent reports of gray matter reductions in the cingulate cortex and precuneus, this study assesses CSA, CTh, and ...
Irina Jarvers, Raphael Degmayr, Alexandra Otto, Ricarda Jacob, Wilhelm Malloni, Stephanie Kandsperger, Daniel Schleicher, Angelika Ecker, Isabel Wiesinger, Christina Wendl, Mark Greenlee, Romuald Brunner   +11 more
wiley   +1 more source

A comparison of depot and oral atypical antipsychotics in terms of metabolic syndrome markers

Psychiatry and Clinical Psychopharmacology, 2018
OBJECTIVES: The duration of life of patients with schizophrenia is shorter than that of the general population for various reasons. Especially cardiovascular diseases are one of the most important causes of death in patients with schizophrenia.
Demet Sağlam Aykut, Evrim Özkorumak Karagüzel   +1 more
doaj   +1 more source

Mechanisms of development of antipsychotic-induced metabolic disorders: pharmacogenetic aspect

Бюллетень сибирской медицины, 2018
Antipsychotics are the main drug group in the treatment of disorders of the schizophrenic spectrum. At the same time, this drug group requires long-term use, has a narrow therapeutic breadth and a large spectrum and high severity of undesirable drug ...
R. F. Nasyrova, M. Yu. Tolmachev, D. A. Sychev, K. K. Yakhin, N. G. Neznanov   +4 more
doaj   +1 more source

Neurofeedback for Binge‐Eating Disorder: Neurophysiological Outcome Predictors and Rapid Response

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Pioneer studies suggested the effectiveness of food‐specific electroencephalography (EEG) and real‐time functional near‐infrared spectroscopy (rtfNIRS) neurofeedback (NF) trainings in the treatment of binge‐eating disorder (BED). These trainings aim to improve participants' neurophysiological self‐regulation.
Ben Schreglmann, Ricarda Schmidt, Michael Lührs, Anja Hilbert   +3 more
wiley   +1 more source